Peroxisome Proliferator-Activated Receptors

TopicLeading institutions, researchers & key papers

This cluster of papers focuses on the Peroxisome Proliferator-Activated Receptors (PPARs), a group of nuclear receptors that play a crucial role in regulating metabolism, inflammation, lipid physiology, and various metabolic diseases such as obesity and diabetes. The cluster explores the diverse biology, mechanisms of action, and therapeutic implications of PPARs, including their involvement in transcriptional regulation and the role of fatty acid-binding proteins.

233

Works

IDs:OpenAlex

How has Peroxisome Proliferator-Activated Receptors's publication output changed over time?

ScholarIQpublication output · 2000–2017

Output grew0% over the shown period — from 1 works in 2000 to 1 in 2017.

2000200120022003200420052006200820152017

What are the most-cited papers on Peroxisome Proliferator-Activated Receptors?

ScholarIQmost cited works

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

John Dormandy, B Charbonnel, D.J.A. Eckland, Erland Erdmann, Massimo Massi‐Benedetti, Ian K. Moules, Allan M. Skene, Meng H. Tan, Pierre J. Lefèbvre, Gordon Murray, Eberhard Standl, Robert G. Wilcox, Lars Wilhelmsen, John Betteridge, Kåre I. Birkeland, Alain Golay, Robert J. Heine, László Korányi, Markku Laakso, Marian Mokáň, Antanas Norkus, Valdis Pīrāgs, Toomas Podar, André Scheen, Werner A. Scherbaum, Guntram Schernthaner, Ole Schmitz, J Skrha, Ulf Smith, J Tatoń

The Lancet. 20054,139 CitationsOPEN ACCESS

Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy

Steven E. Kahn, Steven M. Haffner, Mark Heise, William H. Herman, Rury R. Holman, Nigel C. Jones, Barbara G. Kravitz, John M. Lachin, Mark O’Neill, Bernard Zinman, Giancarlo Viberti

New England Journal of Medicine. 20062,958 Citations

Short-Chain Fatty Acids Protect Against High-Fat Diet–Induced Obesity via a PPARγ-Dependent Switch From Lipogenesis to Fat Oxidation

Gijs den Besten, Aycha Bleeker, Albert Gerding, Karen van Eunen, Rick Havinga, Theo H. van Dijk, Maaike H. Oosterveer, Johan W. Jonker, Albert K. Groen, Dirk‐Jan Reijngoud, Barbara M. Bakker

S129060628. 20151,114 Citations

Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats.

Akira Okuno, Hiroyuki Tamemoto, Kazuuki TOBE, Kohjiro Ueki, Yusaku Mori, K Iwamoto, Kazuhiko Umesono, Y. Akanuma, Takuya Fujiwara, Hiroyoshi Horikoshi, Y Yazaki, Takashi Kadowaki

S114430552. 1998999 CitationsOPEN ACCESS

Hematopoietic Stem-Cell Gene Therapy for Cerebral Adrenoleukodystrophy

Florian Eichler, Christine Duncan, Patricia L. Musolino, Paul J. Orchard, Satiro De Oliveira, Adrian J. Thrasher, Myriam Armant, Colleen Dansereau, Troy C. Lund, Weston P. Miller, Gerald V. Raymond, Raman Sankar, Ami J. Shah, Caroline Sevin, H. Bobby Gaspar, Paul Gissen, Hernán Amartino, Drago Bratkovic, Nicholas Smith, Asif Paker, Esther Shamir, Tara O’Meara, David Davidson, Patrick Aubourg, David A. Williams

New England Journal of Medicine. 2017599 Citations